ClinicalTrials.gov
public full text
Public Domain
A Study of Lung Clearance After Hypertonic Saline Delivery Using the tPAD Device
The primary objective of this study is to determine whether a single overnight, eight-hour administration of a 7% NaCl solution delivered by the Parion Sciences transnasal Pulmonary Aerosol Delivery (tPAD) device has a significant effect on mucociliary clearance in subjects with cystic fibrosis, as compared to no treatment. This study will be conducted at the University of Pittsburgh Medical Center.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease#1111758
- The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non Cystic Fibrosis Bronchiectasis#1095695
- Researching the Effects of Airway Clearance Therapies in Cystic Fibrosis#812047
- Tolerability of Hypertonic Saline in Infants With Cystic Fibrosis#880707
- The Effects of Long Term Inhalation of Hypertonic Saline in Subjects With Cystic Fibrosis#915518
Record · ID 874588
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive